These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28884937)

  • 101. Minocycline in the eradication of
    Zhou K; Li CL; Zhang H; Suo BJ; Zhang YX; Ren XL; Wang YX; Mi CM; Ma LL; Zhou LY; Tian XL; Song ZQ
    World J Gastroenterol; 2024 May; 30(17):2354-2368. PubMed ID: 38813048
    [TBL] [Abstract][Full Text] [Related]  

  • 102. First-Line
    Sue S; Suzuki N; Shibata W; Sasaki T; Yamada H; Kaneko H; Tamura T; Ishii T; Kondo M; Maeda S
    Gastroenterol Res Pract; 2017; 2017():2019802. PubMed ID: 29181022
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The efficacy and safety of vonoprazan in quadruple therapy for
    Zhuang X; Jiang H; Jin D; Sun M; Wang Z; Wang X
    Gastroenterol Rep (Oxf); 2024; 12():goae036. PubMed ID: 38628396
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Gisbert JP; Gonzalez L; Calvet X
    Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for
    Mahmoud A; Abuelazm M; Ahmed AAS; Abdalshafy H; Abdelazeem B; Brašić JR
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235778
    [No Abstract]   [Full Text] [Related]  

  • 106. Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.
    Gisbert JP; Barrio J; Modolell I; Molina-Infante J; Aisa AP; Castro-Fernández M; Rodrigo L; Cosme A; Gisbert JL; Fernández-Bermejo M; Marcos S; Marín AC; McNicholl AG
    Dig Dis Sci; 2015 Feb; 60(2):458-64. PubMed ID: 25236423
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line
    Kakiuchi T
    Front Pharmacol; 2023; 14():1216433. PubMed ID: 37538185
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for
    Kim SJ; Chung JW; Woo HS; Kim SY; Kim JH; Kim YJ; Kim KO; Kwon KA; Park DK
    World J Gastroenterol; 2019 Dec; 25(46):6790-6798. PubMed ID: 31857780
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.
    Sezgin O; Aydın MK; Özdemir AA; Kanık AE
    Turk J Gastroenterol; 2019 May; 30(5):420-435. PubMed ID: 31060997
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis.
    Guo B; Cao NW; Zhou HY; Chu XJ; Li BZ
    Microb Pathog; 2021 Mar; 152():104661. PubMed ID: 33249167
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trial.
    Kakiuchi T; Mizoe A; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Nakayama A; Okuda M; Matsuo M
    Helicobacter; 2020 Jun; 25(3):e12690. PubMed ID: 32207209
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
    Ouyang Y; Wang M; Xu YL; Zhu Y; Lu NH; Hu Y
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1666-1672. PubMed ID: 35716370
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Is short-term therapy really sufficient to eradicate Helicobacter pylori infection?
    Zhou N; Chen WX; Zhang W; Li L; Jin X; Li YM
    J Zhejiang Univ Sci B; 2010 Sep; 11(9):690-701. PubMed ID: 20803773
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials.
    Tang HL; Li Y; Hu YF; Xie HG; Zhai SD
    PLoS One; 2013; 8(4):e62162. PubMed ID: 23646118
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
    Chen MJ; Chen CC; Chen YN; Chen CC; Fang YJ; Lin JT; Wu MS; Liou JM;
    Am J Gastroenterol; 2018 Oct; 113(10):1444-1457. PubMed ID: 30171216
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.
    Sereni G; Azzolini F; Camellini L; Formisano D; Decembrino F; Iori V; Tioli C; Cavina M; Di Mario F; Bedogni G; Sassatelli R
    World J Gastroenterol; 2012 Sep; 18(33):4542-8. PubMed ID: 22969227
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
    Essa AS; Kramer JR; Graham DY; Treiber G
    Helicobacter; 2009 Apr; 14(2):109-18. PubMed ID: 19298338
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
    Marin AC; Nyssen OP; McNicholl AG; Gisbert JP
    Drugs; 2017 May; 77(7):765-776. PubMed ID: 28361211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.